160 related articles for article (PubMed ID: 24002681)
1. Downregulation of tumstatin expression by overexpression of ornithine decarboxylase.
Wang W; Xu CX; Hou GS; Chen YG; Xin JX; Liu XX
Oncol Rep; 2013 Nov; 30(5):2042-8. PubMed ID: 24002681
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro.
Xu CX; Yan YF; Yang YP; Liu B; Xin JX; Chen SM; Wang W; Jiang CY; Lu ZX; Liu XX
Mol Biol Rep; 2011 Feb; 38(2):949-55. PubMed ID: 20533091
[TBL] [Abstract][Full Text] [Related]
3. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
4. Tumstatin transfected into human glioma cell line U251 represses tumor growth by inhibiting angiogenesis.
Ye HX; Yao Y; Jiang XJ; Yuan XR
Chin Med J (Engl); 2013; 126(9):1720-5. PubMed ID: 23652057
[TBL] [Abstract][Full Text] [Related]
5. The expression of tumstatin is down-regulated in renal carcinoma.
Xu CX; Liu XX; Hou GS; Yan YF; Chen SM; Wang W; Jiang GS; Liu B; Xin JX
Mol Biol Rep; 2010 Jun; 37(5):2273-7. PubMed ID: 19688274
[TBL] [Abstract][Full Text] [Related]
6. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model.
Chung IS; Son YI; Ko YJ; Baek CH; Cho JK; Jeong HS
Oral Oncol; 2008 Dec; 44(12):1118-26. PubMed ID: 18485794
[TBL] [Abstract][Full Text] [Related]
7. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y; Kalluri R
Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression.
Nemoto T; Hori H; Yoshimoto M; Seyama Y; Kubota S
Blood; 2002 Feb; 99(4):1478-81. PubMed ID: 11830503
[TBL] [Abstract][Full Text] [Related]
10. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
11. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion.
Kubota S; Kiyosawa H; Nomura Y; Yamada T; Seyama Y
J Natl Cancer Inst; 1997 Apr; 89(8):567-71. PubMed ID: 9106645
[TBL] [Abstract][Full Text] [Related]
12. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
Burgess JK; Boustany S; Moir LM; Weckmann M; Lau JY; Grafton K; Baraket M; Hansbro PM; Hansbro NG; Foster PS; Black JL; Oliver BG
Am J Respir Crit Care Med; 2010 Jan; 181(2):106-15. PubMed ID: 19875687
[TBL] [Abstract][Full Text] [Related]
13. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y; Colorado PC; Kalluri R
J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.
Oliveira-Ferrer L; Wellbrock J; Bartsch U; Penas EM; Hauschild J; Klokow M; Bokemeyer C; Fiedler W; Schuch G
Mol Cancer; 2013 Nov; 12(1):144. PubMed ID: 24257371
[TBL] [Abstract][Full Text] [Related]
15. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
[TBL] [Abstract][Full Text] [Related]
16. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
Pasco S; Ramont L; Venteo L; Pluot M; Maquart FX; Monboisse JC
Exp Cell Res; 2004 Dec; 301(2):251-65. PubMed ID: 15530861
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo.
Chi W; Song X; Jiang C; Liu X; Li W; Wang X
Tumour Biol; 2006; 27(5):243-51. PubMed ID: 16888408
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated expression of both antisense ornithine decarboxylase and s-adenosylmethionine decarboxylase induces G1 arrest in HT-29 cells.
Gong L; Jiang C; Zhang B; Hu H; Wang W; Liu X
J Biochem Mol Biol; 2006 Nov; 39(6):730-6. PubMed ID: 17129409
[TBL] [Abstract][Full Text] [Related]
19. [Ornithine decarboxylase and S-adenosylmethionine decarboxylase bi-antisense virus inhibit growth and invasion of esophageal cancer cell line Eca109].
Song X; Tian H; Liu XX; Zhang B; Li WJ; Xu J
Ai Zheng; 2008 Nov; 27(11):1144-9. PubMed ID: 19000443
[TBL] [Abstract][Full Text] [Related]
20. Effects of eukaryotic expression plasmid encoding human tumstatin gene on endothelial cells in vitro.
Yang YP; Xu CX; Hou GS; Xin JX; Wang W; Liu XX
Chin Med J (Engl); 2010 Aug; 123(16):2269-73. PubMed ID: 20819678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
